Yeh TK - Search Results

1

Phase I study of low-dose suramin as a chemosensitizer in patients with advanced non-small cell lung cancer.

Villalona-Calero MA, Wientjes MG, Otterson GA, Kanter S, Young D, Murgo AJ, Fischer B, DeHoff C, Chen D, Yeh TK, Song S, Grever M, Au JL. Villalona-Calero MA, et al. Among authors: yeh tk. Clin Cancer Res. 2003 Aug 15;9(9):3303-11. Clin Cancer Res. 2003. PMID: 12960116 Clinical Trial.

2

Nontoxic suramin as a chemosensitizer in patients: dosing nomogram development.

Chen D, Song SH, Wientjes MG, Yeh TK, Zhao L, Villalona-Calero M, Otterson GA, Jensen R, Grever M, Murgo AJ, Au JL. Chen D, et al. Among authors: yeh tk. Pharm Res. 2006 Jun;23(6):1265-74. doi: 10.1007/s11095-006-0165-1. Epub 2006 May 25. Pharm Res. 2006. PMID: 16715360

3

Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy.

Lu Z, Yeh TK, Tsai M, Au JL, Wientjes MG. Lu Z, et al. Among authors: yeh tk. Clin Cancer Res. 2004 Nov 15;10(22):7677-84. doi: 10.1158/1078-0432.CCR-04-1443. Clin Cancer Res. 2004. PMID: 15570001

4

Formulating paclitaxel in nanoparticles alters its disposition.

Yeh TK, Lu Z, Wientjes MG, Au JL. Yeh TK, et al. Pharm Res. 2005 Jun;22(6):867-74. doi: 10.1007/s11095-005-4581-4. Epub 2005 Jun 8. Pharm Res. 2005. PMID: 15948030

5

Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel.

Tsai M, Lu Z, Wang J, Yeh TK, Wientjes MG, Au JL. Tsai M, et al. Among authors: yeh tk. Pharm Res. 2007 Sep;24(9):1691-701. doi: 10.1007/s11095-007-9298-0. Epub 2007 Apr 20. Pharm Res. 2007. PMID: 17447121 Free PMC article.

6

Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy.

Lu Z, Yeh TK, Wang J, Chen L, Lyness G, Xin Y, Wientjes MG, Bergdall V, Couto G, Alvarez-Berger F, Kosarek CE, Au JL. Lu Z, et al. Among authors: yeh tk. J Urol. 2011 Apr;185(4):1478-83. doi: 10.1016/j.juro.2010.11.091. Epub 2011 Feb 19. J Urol. 2011. PMID: 21334664 Free PMC article.

7

DBPR116, a Prodrug of BPRMU191, in Combination with Naltrexone as a Safer Opioid Analgesic Than Morphine via Peripheral Administration.

Lin SY, Chang YC, Tien YW, Kuo YH, Chang HF, Ou LC, Chen YP, Chang KH, Hsu YT, Huang YC, Yang CM, Law PY, Xi JH, Tao PL, Loh HH, Yeh TK, Zhuang H, Hsieh HP, Shih C, Chen CT, Yeh SH, Ueng SH. Lin SY, et al. Among authors: yeh tk. J Med Chem. 2024 Nov 14;67(21):19777-19790. doi: 10.1021/acs.jmedchem.4c02107. Epub 2024 Oct 29. J Med Chem. 2024. PMID: 39473174

8

Pathogenic Detection by Metagenomic Next-generation Sequencing in Skin and Soft Tissue Infection.

Yeh TK, Huang YT, Liu PY, Mao YC, Lai CS, Lai KL, Tseng CH, Liu CW, Huang WH, Huang HP, Lin KP. Yeh TK, et al. In Vivo. 2024 Sep-Oct;38(5):2364-2373. doi: 10.21873/invivo.13703. In Vivo. 2024. PMID: 39187328 Free PMC article.

9

Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia.

Huang YH, Lin SY, Ou LC, Huang WC, Chao PK, Chang YC, Chang HF, Lee PT, Yeh TK, Kuo YH, Tien YW, Xi JH, Tao PL, Chen PY, Chuang JY, Shih C, Chen CT, Tung CW, Loh HH, Ueng SH, Yeh SH. Huang YH, et al. Among authors: yeh tk. Cell Chem Biol. 2024 Nov 21;31(11):1885-1898.e10. doi: 10.1016/j.chembiol.2024.06.013. Epub 2024 Jul 17. Cell Chem Biol. 2024. PMID: 39025070

10

Development of a Humanized Antibody Targeting Extracellular HSP90α to Suppress Endothelial-Mesenchymal Transition-Enhanced Tumor Growth of Pancreatic Adenocarcinoma Cells.

Fan CS, Hung HC, Chen CC, Chen LL, Ke YY, Yeh TK, Huang CT, Chang TY, Yen KJ, Chen CH, Chua KV, Hsu JT, Huang TS. Fan CS, et al. Among authors: yeh tk. Cells. 2024 Jul 4;13(13):1146. doi: 10.3390/cells13131146. Cells. 2024. PMID: 38994997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters